Jain AB et al. |
Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721270
|
Abu-Elmagd KM et al. |
Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721271
|
DiLella AG and Craig RJ |
Characterization of the human FKBP-12 gene and related pseudogenes. |
1991 |
Transplant. Proc. |
pmid:1721302
|
Kar S and Carr B |
Gene expression of FK 506-binding protein. |
1991 |
Transplant. Proc. |
pmid:1721303
|
Winkler M et al. |
Use of FK 506 for treatment of chronic rejection after liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721334
|
Offner G et al. |
FK 506 in a 14-year-old renal allograft recipient with cyclosporine-related liver nephrotoxicity: 1-year follow-up. |
1991 |
Transplant. Proc. |
pmid:1721366
|
Imai K et al. |
Histopathological study of canine pancreaticoduodenal allotransplantation with FK506, cyclosporine, and triple regimen immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1703347
|
|
Japanese study of FK 506 on kidney transplantation: the benefit of monitoring the whole blood FK 506 concentration. Japanese FK 506 Study Group. |
1991 |
Transplant. Proc. |
pmid:1721367
|
Starzl TE et al. |
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. |
1991 |
Transplant. Proc. |
pmid:1703351
|
de Bruin RW et al. |
Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation. |
1991 |
Transplant. Proc. |
pmid:1721429
|
Vincent SH et al. |
Effects of the immunosuppressant FK-506 and its analog FK-520 on hepatic and renal cytochrome P450 mixed-function oxidase. |
1991 |
Biochem. Pharmacol. |
pmid:1708254
|
Deguchi K et al. |
Effects of FK 506 on acute experimental allergic encephalomyelitis. |
1991 |
Transplant. Proc. |
pmid:1721461
|
Bolton C |
The ability of myelin basic protein-sensitised leukocytes to adoptively transfer experimental allergic encephalomyelitis following coculture with FK 506, cyclosporine, or prednisolone. |
1991 |
Transplant. Proc. |
pmid:1721462
|
Armitage JM et al. |
Preliminary experience with FK506 in thoracic transplantation. |
1991 |
Transplantation |
pmid:1713363
|
Lorber MI et al. |
A comparison of in vivo responses to cyclosporine, FK506, and rapamycin following allogeneic immune challenge. |
1991 |
Transplantation |
pmid:1713364
|
Ryu S and Yasunami Y |
The necessity of differential immunosuppression for prevention of immune rejection by FK506 in rat islet allografts transplanted into the liver or beneath the kidney capsule. |
1991 |
Transplantation |
pmid:1718064
|
Kuroki H et al. |
Morphological and immunological analysis of rats with long-term-surviving limb allografts induced by a short course of FK 506 or cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1703697
|
Starzl TE et al. |
Hepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycin. |
1991 |
Transplantation |
pmid:1718068
|
Stötter H and Lotze MT |
Human lymphokine-activated killer cell activity. Role of IL-2, IL-4, and IL-7. |
1991 |
Arch Surg |
pmid:1726819
|
Karlsson H and Nässberger L |
FK506 lacks the ability to inhibit expression of interleukin-2 receptor beta-chain on human lymphocytes. |
1991 |
J Clin Lab Immunol |
pmid:1726895
|